Piroxicam 10 suppositories 0,02g PIROXICAMUM Пироксикам

Piroxicam Indications

Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis.

Because of the safety profile of piroxicam is not a first-choice, if shown the use of other nonsteroidal anti-inflammatory or anti-rheumatic drugs. The decision to appoint piroxicam should be based on an individual assessment of the overall risk to the patient.

Contraindications

- Ulcer gastrointestinal bleeding or perforation in history;

- Gastrointestinal disease in history, which may lead to bleeding, such as ulcerative colitis, Crohn's disease, cancer of the gastrointestinal tract or diverticulitis;

- Active peptic ulcer, inflammatory gastrointestinal disease or gastrointestinal bleeding;

- Concomitant use with other NSAIDs (NSAIDs), including selective COX-2 inhibitors and acetylsalicylic acid at analgesic doses;

- Concomitant use of anticoagulants;

- Previous serious allergic reactions of any type, especially cutaneous reactions such as erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis;

- Hypersensitivity to the active substances or auxiliary, transient skin reactions (regardless of severity) in response to the use of piroxicam and other nonsteroidal anti-inflammatory and anti-rheumatic drugs and other drugs;

- Severe heart failure;

- Severe renal or hepatic impairment;

- Use of aspirin and other NSAIDs in patients with NSAID induced development of asthma, nasal polyps, angioedema;

- Treatment of perioperative pain in coronary artery bypass grafting.

Dosage & Administration

The primary purpose piroxicam should be made by a doctor who has experience in diagnostic evaluation and treatment of patients with inflammatory or degenerative rheumatic diseases. The maximum recommended dose is 0.02 g

Side effects can be reduced by using the minimum effective dose for the shortest time required for treatment.